Raymond Anderson insider trades

Open-market stock purchases and sales by Raymond Anderson, Director at Monopar Therapeutics, from SEC Form 4 filings since Mar 9, 2010.

Recent trades

DateStockTradeValue
Dec 2, 2025MNPR Monopar TherapeuticsBought (not open market)—

Companies traded

  • MNPR Monopar Therapeutics: other filings, last Dec 2, 2025
  • NONE Monopar Therapeutics: other filings, last Aug 9, 2018
  • RPTP Raptor Pharmaceutical Corp: 23 sales, last Oct 25, 2016

Get free alerts when Raymond Anderson files a new trade →